US Patent 10077318 Cysteine engineered antibodies and conjugates
Patent 10077318 was granted and assigned to Genentech on September, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10077318 Cysteine engineered antibodies and conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.